Medigen Vaccine Biologics Corp.(TW:6547)
NT$51.50+2.80 (+9.81%)
TW:6547
Medigen Vaccine Biologics Corp. Revenue
NT$51.50
At close:+2.80 (+9.81%)
Medigen Vaccine Biologics Corp. (6547) Revenue
Medigen Vaccine Biologics Corp. Revenue
Medigen Vaccine Biologics Corp. had a revenue of 115.05M in the quarter ending Jun 30, 2026, with 8.60%. This bring the company's revenue in the last twelve months to 573.85M, Decreased 4.94%. In the fiscal year ending Dec 31, 2025, Medigen Vaccine Biologics Corp. had annual revenue of 613.17M with 1.24% growth.
- Revenue (ttm)
- 573.85M
- Revenue Growth
- 44.37%
- P/S Ratio
- 27.63
- Revenue/Employee
- TWD 500,139
- Employees
- 1,226
- Market Cap
- TWD 16.94B
Revenue Chart
Medigen Vaccine Biologics Corp. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 613.17M | 7.53M | 1.24% |
| Dec 31, 2024 | 605.64M | 216.01M | 55.44% |
| Dec 31, 2023 | 389.62M | 24.58M | 6.73% |
| Dec 31, 2022 | 365.04M | -2.92B | -88.87% |
| Dec 31, 2021 | 3.28B | 3.27B | 28413.03% |
| Dec 31, 2020 | 11.51M | 10.39M | 927.41% |
| Dec 31, 2019 | 1.12M | 1.12M | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.